PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
26-Nov-2025 Bioreactors Market Market Dynamics, Key Developments, Future Scope, Industry Outlook Medi-Tech Insights
26-Nov-2025 eXmoor Pharma and Royal Free London launch strategic collaboration to strengthen UK cell and gene therapy manufacturing pathway eXmoor Pharma
26-Nov-2025 Custom Antibody Market Set for Dynamic Rise with Key Players; Thermo Fisher Scientific Inc.; Abcam plc; Bio-Rad Laboratories, Inc; Creative Biolabs; Merck KGaA Medi-Tech Insights
26-Nov-2025 Hospital Executives Signal 2026 as Strategic 'Reset Year' ACCESS Newswire
26-Nov-2025 IVD Contract Manufacturing Services Market Projections 2025-2030: Key Trends, Opportunities, and Growth Factors in New Report Medi-Tech Insights
26-Nov-2025 Dental Flap Surgery Market Size, Share, Price and Growth Rate Research Report 2025 Medi-Tech Insights
26-Nov-2025 Modus Therapeutics publishes Interim report for the third quarter 2025 Modus Therapeutics
26-Nov-2025 Alzheimer’s Prevention charity pioneers research on nutrition biomarkers to detect dementia risk from age 18 Food for the Brain Foundation
26-Nov-2025 Medivir presenting at the Aktiespararnas Stora Aktiedagar Medivir
26-Nov-2025 Symbiosis Formally Presented with Prestigious King’s Award by Lord Lieutenant of Stirling and Falkirk Symbiosis
26-Nov-2025 Queen Square launches podcast to support Parkinson's and Essential Tremor patients Queen Square
26-Nov-2025 Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member ACCESS Newswire
26-Nov-2025 Sinceri Senior Living Announces Strategic Expansion & Continued Growth Across Key Markets ACCESS Newswire
26-Nov-2025 enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment ACCESS Newswire
26-Nov-2025 Vivan Therapeutics and the MRC Laboratory of Medical Sciences Announces a Pioneering Partnership to Explore How Specific Cancer Mutations, Diabetes & Diet Influence Drug Response Vivan Therapeutics
26-Nov-2025 Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva® Teva
26-Nov-2025 Sannabis, Inc. (OTC: USPS) Announces Binational Hemp Block Initiative Designed to Strengthen U.S.-Colombia Relations Through Sustainable Industrial Development ACCESS Newswire
26-Nov-2025 VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor ACCESS Newswire
26-Nov-2025 Good Salt Life, Inc.'s Induction Charge Delivery Systems Deployed to Protect Show Horses from Widespread EHV-1 Outbreak ACCESS Newswire
26-Nov-2025 Wellgistics Health Announces Sponsorship of Dream Bowl 2026 and Participation in DataVault AI Dream Bowl 2026 Meme Coin Shareholder Distribution Plan ACCESS Newswire